• / Free eNewsletters & Magazine
  • / My Account
Home>Authors>Damien Conover

Damien Conover

  1. All
  2. Videos
  3. Investing
  1. Johnson & Johnson Looks Overvalued Today

    Third-quarter earnings were ahead of Street expectations, driven mostly by robust growth in the drug division.

  2. The Week Ahead: What to Watch as Netflix, J&J Report

    GE, American Express, CSX, and Goldman Sachs are also set to report this week. Plus, industrial production and housing starts.

  3. Why We Like Eli Lilly Today

    The undervalued pharmaceutical giant is cutting costs and has a strong pipeline, says Damien Conover .

  4. Opportunities in Immuno-Oncology

    New cancer treatments show promise for patients and investors.

  5. Is the Affordable Care Act Healing Health Care’s Woes?

    As the ultimate impact of Obamacare comes into focus, the sector’s winners and losers are becoming more apparent.

  6. Health Care’s Outlook Clarifies

    Obamacare will benefit some sectors more than others, but poor economy and pricing pressures are the biggest challenges most health-care firms must face.

  7. The Future of Big Pharma

    Things look grim, but investors who can bear it could benefit.

  8. Parsing the Berkshire Hathaway Portfolio

    Berkshire's portfolio can give some guidance to weary investors.

©2017 Morningstar Advisor. All right reserved.